Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia

Journal:
Blood
Published:
Affiliations:
20
Authors:
23
Institutions Authors Share
Genetix Biotherapeutics, United States of America (USA)
7.000000
0.30
UCSF Benioff Children's Hospital Oakland, United States of America (USA)
2.000000
0.09
Children's Hospital of Philadelphia (CHOP), United States of America (USA)
1.500000
0.07
University of Pennsylvania (Penn), United States of America (USA)
1.500000
0.07
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States of America (USA)
1.000000
0.04
Hospital Timone, France
1.000000
0.04
George Papanikolaou General Hospital of Thessaloniki, Greece
1.000000
0.04
Ramathibodi Hospital, MU, Thailand
1.000000
0.04
Hannover Medical School (MHH), Germany
1.000000
0.04
Royal Prince Alfred Hospital (RPAH), USYD, Australia
1.000000
0.04
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany
1.000000
0.04
Heidelberg University (Uni Heidelberg), Germany
0.500000
0.02
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
0.500000
0.02
UCL, United Kingdom (UK)
0.500000
0.02
Great Ormond Street Hospital for Children NHS Trust, United Kingdom (UK)
0.500000
0.02
IRCCS Bambino Gesù Children's Hospital, Italy
0.500000
0.02
Catholic University of the Sacred Heart (UCSC), Italy
0.500000
0.02
Clinical Investigation Center in Biotherapy and Immunology (CIC-BTi), France
0.333333
0.01
Imagine Institute, France
0.333333
0.01
Hôpital Necker-Enfants Malades, France
0.333333
0.01